You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 3.9% | 4.1% |
Div Cover | 0.7 | 1.9 |
Op Mrgn | 8.7% | 24.8% |
ROCE | 13.6% |
Latest | Forecast | |
---|---|---|
P/E | 34.9 | 1,311.3 |
PEG | -1.1 | 1.5 |
Price / Revenue | 2.8 | 2.7 |
Price / Book value | 1.7 |
Latest | Forecast | |
---|---|---|
Revenue | 4.8% | -3.5% |
PBT | -37.3% | n/a |
EPS | -32.7% | -7.8% |
DPS | 2.6% | -2.5% |
Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-12-31 | 33,821.00 | 5,812.00 | €3.42 | 22.5 | 19.0 | 1% | €2.96 | 3.8% |
2017-12-31 | 35,055.00 | 5,634.00 | €3.02 | 23.8 | -2.0 | -12% | €3.03 | 4.2% |
2018-12-31 | 34,463.00 | 4,904.00 | €3.46 | 21.9 | 1.5 | 15% | €3.07 | 4.1% |
2019-12-31 | 36,126.00 | 3,077.00 | €2.33 | 38.5 | -1.2 | -33% | €3.15 | 3.5% |
Sanofi to buy biopharmaceutical group Kymab for up to $1.45bn Sharecast News | 11 Jan |
---|---|
Rolls-Royce to put UltraFan 'on ice' until new plane - report Sharecast News | 04 Jan |
GSK and Sanofi delay Covid-19 vaccine Sharecast News | 11 Dec |